New CAR T therapy shows promise in leukemia treatment
Obecabtagene autoleucel (obe-cel) has demonstrated strong efficacy in treating relapsed…
Obecabtagene autoleucel (obe-cel) has demonstrated strong efficacy in treating relapsed B-cell leukemia, with high response rates and minimal side effects.